Orbia Advance Corporation, S.A.B. de C.V. (MXCHF)

Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,269	1,371	4,165	3,371	5,079	4,738
Market Cap Growth	-50.59%	-67.08%	23.55%	-33.63%	7.20%	8.01%
Enterprise Value	6,742	6,208	9,059	8,338	9,362	9,641
Last Close Price	0.65	0.73	2.09	1.74	2.34	2.22
PE Ratio	-	9.46	64.08	5.95	7.73	24.30
PS Ratio	0.17	0.18	0.51	0.35	0.58	0.74
PB Ratio	0.43	0.42	1.16	0.91	1.37	1.37
P/FCF Ratio	2.56	3.65	5.16	4.13	5.35	5.33
P/OCF Ratio	1.58	1.76	2.98	2.62	4.11	4.34
EV/Sales Ratio	0.90	0.83	1.10	0.86	1.07	1.50
EV/EBITDA Ratio	6.19	5.90	6.61	4.59	4.76	7.81
EV/EBIT Ratio	16.16	12.01	10.29	6.25	6.39	13.15
EV/FCF Ratio	13.59	16.51	11.21	10.21	9.86	10.85
Debt / Equity Ratio	1.96	1.67	1.61	1.50	1.17	1.31
Debt / EBITDA Ratio	5.33	4.66	3.86	2.89	2.11	3.39
Debt / FCF Ratio	11.68	14.57	7.12	6.77	4.58	5.07
Asset Turnover	0.65	0.66	0.71	0.87	0.85	0.63
Inventory Turnover	4.84	5.02	4.80	5.44	5.74	5.52
Quick Ratio	1.03	0.94	1.15	1.05	0.90	0.85
Current Ratio	1.54	1.37	1.64	1.51	1.41	1.22
Return on Equity (ROE)	-2.76%	6.49%	4.28%	17.96%	21.55%	9.63%
Return on Assets (ROA)	2.28%	2.86%	4.75%	7.51%	8.80%	4.52%
Return on Capital (ROIC)	3.01%	3.57%	5.92%	9.65%	11.43%	5.83%
Return on Capital Employed (ROCE)	4.60%	6.10%	9.80%	15.60%	18.40%	9.60%
Earnings Yield	-12.29%	10.58%	1.56%	16.82%	12.93%	4.12%
FCF Yield	39.07%	27.42%	19.40%	24.24%	18.70%	18.76%
Dividend Yield	6.49%	11.48%	4.50%	-	-	4.50%
Payout Ratio	-	110.34%	369.23%	52.73%	30.44%	117.95%
Buyback Yield / Dilution	-1.68%	0.10%	0.38%	3.70%	1.59%	2.06%
Total Shareholder Return	4.81%	11.58%	4.88%	3.70%	1.59%	6.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.